Skip to main content
SpringerPlus
Fig. 1 | SpringerPlus

Fig. 1

From: Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: a long-term mono-center study

Fig. 1

Treatment schema and distribution of patients. AE adverse events, CR complete response, HD-MTX high-dose methotrexate, HDC high-dose chemotherapy, ASCT autologous stem-cell transplantation, PD progressive disease, PR partial response, RTX rituximab, WBR whole brain radiotherapy

Back to article page